MD, MBA, FASTRO
Dr. Amar Rewari
Dr. Amar Rewari is one of the nation's most visible physician voices on cancer care and health policy. A board-certified radiation oncologist and Yale-trained MD/MBA, he has made more than 75 national television, print, and podcast appearances in outlets including NBC News, LIVE with Kelly and Mark, USA Today, People, ABC, Politico, and NewsNation, syndicated into more than 200 media placements appearing in outlets with a combined reach of more than 2.5 billion monthly visitors. He is a founder and co-host of Value Health Voices (ACRO National Media Award, 2025), a podcast examining the money, policy, and market forces shaping American healthcare, with guests from across the policy spectrum including former MedPAC Chair Dr. Michael Chernew, former CMS Medicare Director Dr. Meena Seshamani, AMA CEO Dr. John Whyte, oncologist and former White House Health Policy Advisor Dr. Zeke Emanuel, and Mark Cuban.
Dr. Rewari is the Chief of Radiation Oncology for Luminis Health, where he leads a department spanning a hospital-based flagship and two freestanding centers while maintaining a full clinical practice. He is also an Adjunct Assistant Professor at the Johns Hopkins University School of Medicine, where he teaches physicians in healthcare policy, economics, and value-based care, and an Affiliate Scholar of the Hopkins Business of Health Initiative.
A national leader in health policy and payment reform, Dr. Rewari serves on the Board of Directors of the American Society for Radiation Oncology (ASTRO), where he chairs the Health Policy Council and the Corporate Advisory Council. He advises the American Medical Association's RVS Update Committee (RUC) on Medicare valuation of physician services and helped create the Radiation Oncology Case Rate (ROCR), a national value-based payment model for cancer care.
His perspective is grounded in an earlier career in healthcare investment banking at Credit Suisse and payer strategy in the Office of the Chairman at Aetna, and in nonprofit governance as past Board Chair of the Fund for Education Abroad.
Dr. Rewari received both his MD and MBA from Yale University and completed his radiation oncology residency at Rutgers, where he served as chief resident. He is an avid traveler and foodie who enjoys scuba, sailing, skiing, and tennis.
Professional Summary
Physician executive and oncology leader with over 20 years of combined experience in clinical medicine, healthcare finance, and health policy. Dual-trained with an MD and MBA from Yale University, bringing a multidisciplinary perspective to cancer care delivery, organizational strategy and management, and value-based care.
Currently serves as Chief of Radiation Oncology at Luminis Health, overseeing clinical operations, strategic planning, and business development across a regional radiation oncology network spanning a hospital-based flagship and two freestanding centers. As Adjunct Assistant Professor in the Department of Radiation Oncology at Johns Hopkins School of Medicine and Affiliate Scholar at the Hopkins Business of Health Initiative, teaches and mentors physicians in health policy and healthcare economics.
Nationally, serves on the Board of Directors of the American Society for Radiation Oncology (ASTRO) and chairs both the Health Policy Council and the Corporate Advisory Council, leading initiatives in physician payment reform, advocacy, value-based innovation, and strategic collaboration between providers and industry, including negotiation of multi-stakeholder consensus at the AMA RUC on new radiation therapy delivery codes and helping create the Radiation Oncology Case Rate (ROCR) value-based payment model. Earlier experience in healthcare investment banking at Credit Suisse provides a strong foundation in financial analysis and market strategy that informs a system-level approach to health system management and reimbursement design.
Founder and co-host of the Value Health Voices podcast (ACRO National Media Award, 2025), which examines healthcare policy, economics, and reform for clinicians and health system leaders, and former Chair of the Board of the Fund for Education Abroad, advancing nonprofit governance and global education access for students with financial need. Frequently featured by national media outlets including NBC News, USA Today, People, Medscape, and LIVE with Kelly and Mark — generating more than 150 media placements in the first half of 2026 alone with a combined audience of more than two billion monthly viewers — recognized for bridging medicine, management, and public engagement to advance equitable and financially sustainable models of care.
Core Competencies
Strategic Planning | Health Policy & Economics | Financial Analysis | Clinical Operations | Business Development | Nonprofit Governance | Board Leadership | Organizational Management | Education | Media & Public Engagement
Demographic and Personal Information
Current Appointments
2021 – Present: Chief of Radiation Oncology, Luminis Health, Annapolis MD
2024 – Present: Adjunct Assistant Professor, Department of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore MD
2026 – Present: Affiliate Scholar, Hopkins Business of Health Initiative, Johns Hopkins University, Baltimore MD
Personal Data
E-mail: rewari.md@gmail.com
linkedin.com/in/amar-rewari-md-mba
Education and Training
Undergraduate
1997 – 2001: Bachelor of Arts (BA) in Political Science, Summa Cum Laude, Temple University, Philadelphia, PA
Doctoral/Graduate
2001 – 2006: Doctor of Medicine (MD), Yale University School of Medicine, New Haven, CT
2004 – 2006: Master of Business Administration (MBA), Yale University School of Medicine, New Haven, CT
Clinical Training
2006 – 2007: Yale University School of Medicine, New Haven, CT — Preliminary Year Resident, Department of Internal Medicine
2008 – 2012: Rutgers University – Robert Wood Johnson Medical School, New Brunswick, NJ — Department of Radiation Oncology, Chief Resident 2011–2012
2011: Harvard Medical School – Massachusetts General Hospital, Boston, MA — Proton therapy elective, Department of Radiation Oncology
2024: Johns Hopkins University School of Medicine, Baltimore, MD — Proton Therapy Certificate Course
Experience
Clinical Experience
2012 – 2021 — Radiation Oncologist and Partner, Associates in Radiation Medicine, P.C.
Led development of stereotactic radiosurgery (SRS) and high-dose-rate (HDR) brachytherapy programs, expanding advanced radiation treatment capabilities within the practice.
Evaluated referrals for proton therapy and other advanced radiation modalities, coordinating treatment selection with regional academic centers.
Participated in strategic and operational decision-making as a physician partner, contributing to technology adoption and clinical program growth.
2021 – Present — Chief of Radiation Oncology, Luminis Health
Lead clinical operations, strategic planning, business development, and physician leadership across a regional radiation oncology network spanning a hospital-based flagship and two freestanding centers.
Directed the replacement of an outdated freestanding center, developing and opening a new radiation oncology center in a new location in 2024 with uninterrupted patient care, expanding regional access to advanced cancer care services.
Achieved American College of Radiology (ACR) reaccreditation across all radiation oncology sites in 2026.
Founded and serve as Medical Director of the Low-Dose Radiation Therapy Program for Benign Diseases, expanding clinical service offerings and regional referral growth.
Develop regional partnerships with academic institutions and payer organizations to expand research collaborations, increase clinical volume, and reduce referral leakage.
Advise executive leadership on system-wide capital investments in oncology technology and infrastructure as a member of the Luminis Health Capital Committee.
Chair the American College of Surgeons Commission on Cancer Committee, leading successful reaccreditation of the oncology service line in 2024.
Organize and lead strategic planning retreats for the radiation oncology service line and co-lead cancer service line strategic planning with peer division chiefs, shaping growth initiatives spanning rapid-access diagnostic clinics, AI-enabled clinical trial matching, early-onset cancer and survivorship services, prehabilitation, and theranostics.
Serve on the monthly cancer chiefs council with medical oncology, gynecologic oncology, thoracic oncology, and breast surgery leadership; participate in monthly oncology finance reviews with the health system president and finance and revenue cycle leadership.
Led operational improvements including a 48-hour new-patient access standard with improved patient satisfaction, standardized billing compliance, and redesigned physician peer review.
Govern freestanding radiation oncology joint ventures with hospital capital partners.
Other Professional Experience
2005 — Health Policy Associate, Office of the Chairman, Aetna
Authored and presented a policy white paper to the CEO on an individual insurance mandate informed by Massachusetts Health Care Reform, contributing to Aetna becoming the first major insurer to publicly endorse the policy.
2007 – 2008 — Investment Banking Associate, Credit Suisse Healthcare Group
Advised managed care, medical device, and pharmaceutical clients on transactions, market analysis, and strategic valuation.
2019 – 2025 — Board of Trustees, Fund for Education Abroad Board Chair (2023–2025), Board Vice-Chair (2021–2023), Finance Committee Chair (2019–2021)
Led governance of the nation's largest independent study abroad scholarship provider, overseeing the award of more than $3.5 million in scholarships to over 1,000 students.
Organized and led board strategic planning retreats; oversaw the executive director search and succession; developed access-partner revenue agreements returning 30% to operating support.
2024 – Present — Board of Directors, American Society for Radiation Oncology
Serve on the governing board of the world's largest radiation oncology professional society, helping guide organizational strategy and national initiatives related to physician reimbursement policy, advocacy, education, and quality improvement in cancer care.
Chair the ASTRO Health Policy Council, overseeing the society's policy development and advocacy efforts related to Medicare physician payment, coverage policy, and regulatory issues affecting radiation oncology.
Represent ASTRO at the American Medical Association Relative Value Update Committee (RUC) as RUC Advisor, participating in national physician payment policy discussions and valuation of medical services within the Medicare Physician Fee Schedule.
Lead collaboration between ASTRO and corporate partners as Chair of the Corporate Advisory Council, fostering strategic partnerships that support research, education, patient safety initiatives, and professional society programming.
Help lead board strategic planning retreats shaping direction on membership value and growth, advocacy, education, quality, corporate engagement, and long-term financial sustainability.
Negotiated multi-stakeholder consensus at the AMA RUC on new radiation therapy delivery codes, averting a potential specialty-wide Medicare reimbursement cut approaching 20%; helped create the Radiation Oncology Case Rate (ROCR) value-based payment model.
Co-created non-dues revenue programs, including industry research training fellowships, a sponsored radiopharmaceutical task force, and corporate patient-education partnerships.
2024 – Present — Founder and Co-Host, Value Health Voices Podcast valuehealthvoices.com
Co-create and host a national podcast examining U.S. healthcare policy, economics, and system reform, decoding the money, policy, and market forces shaping American healthcare (ACRO National Media Award, 2025).
Lead in-depth discussions on Medicare Advantage, provider reimbursement, drug pricing, utilization management, prior authorization, and health system financing.
Interview leaders from across the policy spectrum, including former MedPAC Chair Dr. Michael Chernew, former CMS Medicare Director Dr. Meena Seshamani, AMA CEO Dr. John Whyte, longtime KFF Medicare policy director Dr. Tricia Neuman, Paragon Health Institute's Brian Blase, SCAN Group CEO Dr. Sachin Jain, and Mark Cuban.
2025 – Present — National Media Contributor and Physician Commentator
Provide national media commentary on cancer prevention, oncology care delivery, and health policy across television, print, and digital outlets including NBC News, USA Today, People, Medscape, and LIVE with Kelly and Mark.
Original interviews and features syndicated widely across national and regional outlets, generating more than 150 media placements in the first half of 2026 alone, with a combined audience of more than two billion monthly viewers.
Serve as a physician expert for journalists nationwide, translating complex oncology and health policy issues into accessible public education on cancer risk, early detection, reimbursement policy, and access to care.
Recognition
Awards and Honors
2026: Affiliate Scholar Appointment, Hopkins Business of Health Initiative, Johns Hopkins University
2025: ACRO National Media Award for Value Health Voices Podcast
2024: ASTRO Board of Directors Appointment
2024: Fellow (FASTRO), ASTRO
2016–2017: Health Policy Fellow, Inaugural class, ASTRO
2011: Clinical Research Award, ASTRO Annual Meeting
2011: RSNA Resident/Fellow Research Award
2011: BEST Medical Inc. Scholarship, Head & Neck Elective at The Royal Marsden Hospital
2010: Dean's Research Award, Best Publication, Robert Wood Johnson Medical School
2010: Travel Grant, ARS Annual Meeting, Cancun, Mexico
2010: Travel Grant, ACRO Annual Meeting, Orlando, FL
2009–2010: Travel Grants, ASTRO Advocacy Days, Washington, D.C.
2009: NCCN Fellows Recognition Program, NCCN Annual Meeting, Hollywood, FL
2005: Young Oncologist Essay Award, ARS Annual Meeting, Barcelona, Spain
2004: Frederick Frank Fellowship for International Leadership Potential
2002: NIH Short-Term Research Training Grant
2000: Fulbright Scholar Finalist
2000: Phi Beta Kappa Honor Society
Invited Talks
2019: Valuing New Technologies and Their Implications. ACR Annual Meeting, Washington, DC.
2020: Radiation Oncology Economics, Practice Valuation, and Well Qualified Private Practice Candidates. ARRO Annual Meeting, Virtual.
2020: Code Development and Valuation: What Radiation Oncology Industry Stakeholders Need to Know. ASTRO Annual Meeting, Virtual.
2020: Advocacy in Healthcare Policy and Economics. ACR Webinar, Virtual.
2020: Protecting Your Radiation Oncology Service Line During the Transition to Value-Based Care. ACCC Annual Meeting, Washington, DC.
2022: Radiation Oncology Policy Challenges: Medicare Payment Systems & Prior Authorization. ACR Annual Meeting, Washington, DC.
2023: Reimbursement: Per patient rather than per fraction. SCAROP, Arlington, Virginia.
2023: Health Policy Issues facing Radiation Oncology. Mid-Atlantic Radiation Oncology Consortium, George Washington University, Washington, DC.
2024: Radiation Therapy for Benign Conditions. Hematology and Cancer Care for the Primary Care Community Conference, Luminis Health, Annapolis, MD.
2024: Examining the Role of Artificial Intelligence in Utilization Management Practices. Cancer Support Community Utilization Management Summit, Washington, DC.
2025: Trends in Utilization Management and Prior Authorization. Cancer Policy Roundtable, NCCS, Washington, DC.
2025: Fall Summit. Washington Health Innovation Council, Washington, DC.
2026: Revised Treatment Delivery Codes and ROCR Update. SCAROP Meeting, Virtual.
2026: Case Based Discussion: SBRT. RSS Scientific Meeting, Orlando, FL.
2026: ROCR Update. RSS Scientific Meeting, Orlando, FL.
2026: Best Business Practices: Reimbursement & Billing. RSS Scientific Meeting, Orlando, FL.
2026: The Rise of Early-Onset Cancer and What to Do Next. Becker's Oncology Executive Summit, Chicago, IL.
2026: Radiation Oncology Challenges. Community Oncology Alliance Annual Meeting, Orlando, FL.
2026: ASTRO Advocacy Day. Washington, DC.
Grand Rounds
2019: Radiation Oncology Economics and Practice Assessment. Rutgers University, Department of Radiation Oncology, New Brunswick, NJ.
2019: Principles of Radiation Oncology for Post-Mastectomy Radiation including Oncology Staging. Adventist Healthcare, Shady Grove Medical Center, Rockville, MD.
2019: Radiation Oncology for the Plastic Surgeon. Georgetown University, Department of Plastic Surgery, Washington, DC.
2021: Radiation Oncology 101 and Principles for Post-Mastectomy Radiation. Department of Medicine, Luminis Health, Annapolis, MD.
2024: ROCR: A new Era in Radiation Oncology Payment. Department of Radiation Oncology, Johns Hopkins School of Medicine, Baltimore, MD.
Visiting Professorships
2023: Current physician reimbursement in a fee-for-service model: How the sausage gets made. Johns Hopkins University School of Medicine, Department of Radiation Oncology, Baltimore, MD.
2023: Shifting to Value Based Care: A New Era in Radiation Oncology Payment. Johns Hopkins University School of Medicine, Department of Radiation Oncology, Baltimore, MD.
2024: Radiation Oncology Coding and Billing 101. Johns Hopkins University School of Medicine, Department of Radiation Oncology, Baltimore, MD.
2024: Radiation Oncology Workforce, Incentive Models, the Interview and Negotiation Process. Johns Hopkins University School of Medicine, Department of Radiation Oncology, Baltimore, MD.
Posters
2009: Prognostic Value of p53 Expression in Patients Treated with Breast Conserving Therapy. ASTRO Annual Meeting, Chicago, IL.
2010: Role of ERCC1 Expression as a Prognostic Marker for Response to Radiotherapy in Early-Stage Laryngeal Cancer. ASTRO Annual Meeting, San Diego, CA.
Oral/Podium Presentations at Scientific Meetings
2005: Postoperative Concurrent Chemoradiotherapy with Mitomycin in Advanced Squamous Cell Carcinoma of the Head and Neck: Results from Three Prospective Randomized Trials. ARS Annual Meeting, Barcelona, Spain.
2007: BCCIP: A Novel Marker for Radiotherapy Benefit in Patients with Laryngeal Cancer. ASCO Annual Meeting, Chicago, IL.
2010: Prognostic Value of p16 Expression in Laryngeal Cancer Patients Treated with Radiation. ASTRO Annual Meeting, San Diego, CA.
2010: Cigarette Smoking and Risk of Contralateral Breast Cancer and Second Primary Malignancies in Women Treated with Breast Conserving Therapy. ARS Annual Meeting, Cancun, Mexico.
2019: Code Development and Valuation: What Radiation Oncology Industry Stakeholders Need to Know. ASTRO Annual Meeting, Chicago, IL.
2025: Presidential Symposium. Coding Relief: Billing Radiation for Benign Conditions. ASTRO Annual Meeting, San Francisco, CA.
Publications
Original Research
Harris E, Daroui P, Gonzalez V, Ye J, Gao W, Park C, Rewari A, Suh W, Novick K, Choi I. American Radium Society Appropriate Use Criteria Report on the Radiation in the Management of DCIS of the Breast. Clinical Breast Cancer. 2025, Oct.
Novick K, Rewari A, Chadha M, Daroui P, Freedman G, Gao W, Hunt K, Park C, Suh W, Walker E, Wong J, Harris E. American Radium Society Appropriate Use Criteria Postmastectomy Radiation Therapy: Executive Summary of Clinical Topics. Int. Journal of Radiation Oncology, Biology, Physics. 2023, Jul.
Yashar C, Rewari A, Hubbard A. The Changing Practice of Radiation Oncology, Current Trends in Treatment Delivery and the Impact on Practice Economics. ASTRO News. Spring, 2022.
Hoover A, Rewari A, Chen R. Does Bigger Practice Size Mean Better for Patients and Providers? Int. Journal of Radiation Oncology, Biology, Physics. 2021, Nov; 619–621.
Kotha V, Rewari A, Wu H, Lakhiani C, Zolper E, Orio P, Stimac G, Chadab T, Fan K, Evans K, Song D. Radiation Oncology Principles for Plastic and Reconstructive Surgery. Plastic and Reconstructive Surgery. February 2021.
Thakur N, Rewari A, Hubbard A. Future of Alternative Payment Models and Big Data Analytics in the Post-COVID-19 Era: Implications for Radiation Oncology. Int. Journal of Radiation Oncology, Biology, Physics. 2020, Oct; 353–355.
Royce T, Sanoff H, Rewari A. Telemedicine for Cancer Care in the time of COVID-19. JAMA Oncology. 2020 Jul.
Rewari A, Mantz C. The business of radiation oncology after COVID-19: The future is not what it used to be. ASTRO News. 2020 Jul.
Lewin AA, Moy L, Baron P, Didwania AD, diFlorio-Alexander RM, Hayward JH, Le-Petross HT, Newell MS, Rewari A, Scheel JR, Stuckey AR, Suh WW, Ulander GA, Vincoff NS, Weinstein SP, Slanetz PJ. ACR Appropriateness Criteria Stage 1 Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women. J Am Coll Radiol. 2019 Nov; S428–S439.
Johung K, Rewari A, Wu H, Judson B, Contessa JN, Haffty BG, Decker RH. Role of excision repair cross-complementation 1 expression as a prognostic marker for response to radiotherapy in early-stage laryngeal cancer. Head and Neck. 2012 Jun; 852–7.
Rewari A, Lu H, Yang Q, Shen Z, Haffty BG. BCCIP: A Novel Marker for Radiotherapy Benefit in Patients with Laryngeal Cancer. Radiotherapy and Oncology. 2009 Feb; 183–8.
Rewari A, Haffty BG, Wilson LD, Son YH, Joe JK, Ross DA, Papac RJ, Sasaki CT, Fischer JJ. Postoperative Concurrent Chemoradiotherapy with Mitomycin in Advanced Squamous Cell Carcinoma of the Head and Neck: Results from Three Prospective Randomized Trials. The Cancer Journal. 2006 Mar-Apr; 123–9.
Chang W, Rewari A, Centrella M, McCarthy TL. Fos-related antigen 2 controls protein kinase A-induced CCAAT/enhancer-binding protein beta expression in osteoblasts. The Journal of Biological Chemistry. 2004 Oct; 42438–44.
TV and Print Media
2020: Print Interview. OBR Oncology. Proposed CMS Cuts Blasted by Radiation Oncology Group. Link
2023: Print Interview. Politico. Medicare Advantage Care Denials. Link
2025: TV Interview. NBC News Daily. Research Shows More Millennials Diagnosed with Cancer. Link
2025: TV Interview. NBC News Daily. How Prehabilitation Can Benefit Cancer Patients. Link
2025: TV Interview. NBC News Daily. How Prehab Could Be the Future of Cancer Recovery. Link
2025: TV Interview. NewsNation. Morning in America with Markie Martin. Link
2025: TV Interview. Erie News Now Sunrise @ 5. "Pennie" Premiums Set to Climb in 2026. Link
2025: Print Interview. ASTRO Blog. Radiation Oncology Reimbursement Could Face Major Changes in 2026. Link
2025: Print Interview. MDLinx. This Daily Habit Supercharges Chemo and Could Help Colon Cancer Patients Live Longer. Link
2025: Print Interview. MedCentral. Unprecedented Onset of GI Cancers in Young Adults. Link
2025: Print Interview. Men's Journal. 4 Daily Habits to Lower Cancer Risk. Link
2025: Print Interview. Daily Mail+. "Taboo" anal cancer rising among women: survivor story and prevention insights. Link
2025: Print Interview. Woman's World. How to Prevent Colon Cancer in Women Over 50: Lifestyle Tips That Reduce Risk. Link
2025: Print Interview. OncoDaily. Time to Talk About Anal Cancer and HPV Vaccination. Link
2025: Print Interview. SuperAge. The Galleri Cancer Test: Worth It for Early Detection or Not? Link
2025: Print Interview. Patient Power. IVIG Therapy at Home: What to Know. Link
2025: Print Interview. Patient Power. How Is Advanced Prostate Cancer Treated? Link
2025: Print Interview. Mergermarket. Medicaid Cuts Not What the Doctor Ordered for Healthcare M&A. Link
2025: Print Interview. The Independent. Harmful Effects of Insurance Delays on Cancer Care. Link
2025: Print Interview. OncoDaily. Could One Blood Test Detect Cancer Before Symptoms? Link
2025: Print Interview. OncoDaily. The Real History Behind the New Radiation Therapy Treatment Delivery Codes. Link
2025: Print Interview. OncoDaily. How Prior Authorizations Are Affecting Oncology Care. Link
2025: Print Interview. AOL. "Is Your Plan for Me to Die?" Cancer Patients Fighting Insurance Red Tape. Link
2025: Print Interview. OncoDaily. The Shift from Cure to Control and Quality of Life in Advanced Prostate Cancer. Link
2025: Print Interview. OncoDaily. Excited to Speak at ASTRO's Seminar on the 2026 Radiation Oncology Coding Updates. Link
2026: TV Interview. LIVE with Kelly and Mark. Hidden Cancer Dangers in Everyday Habits with Dr. Amar Rewari. Link
2026: TV Interview. NBC News Daily. Raising Awareness on World Cancer Day. Link
2026: TV Interview. NBC News Daily. Key Treatment Options in the Fight Against Cancer. Link
2026: TikTok Interview. Daily Mail. Dawson's Creek star James Van Der Beek has died after a public two-year battle with colorectal cancer. Link
2026: TV Interview. NewsMax. Dr. Amar Rewari on the state of cancer research and why survival rates are rising. Link
2026: TV Interview. NewsMax. Dr. Amar Rewari on deepfake doctors and the rise of social media health advice. Link
2026: Print Interview. Oncology News Central. Oncology Reimbursement Undergoes "Significant Overhaul": 9 Critical Changes to Know. Link
2026: Print Interview. Medscape. 13 Doctors Celebrate Their Mentors. Link
2026: Print Interview. Prevention. Scientists find 8 Lifestyle Factors that Contribute to Cancer Risk — and What to do About Each. Link
2026: Print Interview. Extra.ie. What is Colorectal Cancer? Key Symptoms Explained After Death of James Van Der Beek. Link
2026: Print Interview. Daily Mail. James Van Der Beek's disease is a silent killer: He dismissed his colon cancer symptoms... now experts warn what to watch for. Link
2026: Print Interview. Daily Mail+. Terrifying spike in silent killer cancer baffling doctors: symptoms start quietly but lifestyle tweaks may help prevent it. Link
2026: Print Interview. Daily Mail+. Pancreatic cancer explosion: as cases surge in young people, survivors reveal subtle early signs doctors say to watch for. Link
2026: Print Interview. Daily Mail+. Doctors took five years to realize I had the same "taboo" cancer that killed Catherine O'Hara. Link
2026: Print Interview. WellnessPulse. Prenuvo: Do You Need a $2.5K Full Body MRI Scan? Link
2026: Print Interview. MDLinx. Oncologists are among the highest earners: but the full picture is complicated. Link
2026: Print Interview. Daily Mail+. Doctors reveal the three reasons why you should ask for colonoscopy before the recommended age. Link
2026: Print Interview. MDLinx. Retirement planning for late peaking oncology earners. Link
2026: Print Interview. MDLinx. Private Practice versus Hospital Employment: Which pays off more in oncology? Link
2026: Print Interview. Medscape. Proposed act would fill gaps in cancer survivorship care. Link
2026: Print Interview. Becker's Oncology. How to fix the clinical trial access gap, per 14 oncology leaders. Link
2026: Print Interview. Patient Power. Why Does Radiation Therapy Make You Tired? Link
2026: Print Interview. News Directory. Three types of cancer that remain taboo. Link
2026: Print Interview. Becker's Oncology. The overlooked complexity of outpatient cancer care, per 11 leaders. Link
2026: Print Interview. Medscape. The ACA subsidy gap and its toll on primary care. Link
2026: Print Interview. Parade. Oncologists are begging people to stop using the common cleaning product. Plus, what to do instead. Link
2026: Print Interview. Daily Mail. The $1.75 drink that cures acid reflux. Link
2026: Print Interview. Parade. Oncologists are begging people to throw out this common kitchen item. Plus, safer alternatives that get the job done instead. Link
2026: Print Interview. People. The laundry room staple sparking cancer concerns online — and what experts actually say. Link
2026: Print Interview. Daily Mail. Terrifying stomach cancer explosion sweeps the US: After fitness influencer's shock death, experts reveal subtle early signs that are too often ignored... and lifestyle tweaks that can prevent it. Link
2026: Print Interview. USA Today. Supreme Court sides with weedkiller Roundup, making some MAHA activists angry. Link
2026: Print Interview. Daily Mail. The real reasons for the surge in stomach cancers among the under-50s: Experts say these are the risk factors you need to know. Link
2026: Print Interview. Woman's World. Colon cancer screening guidelines changed: what every woman over 40 needs to know now. Link
2026: Print Interview. Prevention. Scientists link this common condition to higher cancer risk in men. Link
2026: Print Interview. ASTRO News. A case study in media training. Link
2026: Print Interview. New York Post. Rite Aid names 6 more New Hampshire stores for closure as it winds down operations. Link
2026: Print Interview. Parade. I'm an oncologist — this is the cooking oil I always choose. Link
2026: Print Interview. Medscape Medical News. Radiation deserts grow as rural radiation sites are lost, threatening access. Link
2026: Print Interview. Eating Well. A new test could identify colon cancer with one blood draw — here's what an oncologist thinks. Link
Other Media
2020: American Health Law Association Podcast. Fraud and Abuse: COVID-19 and Telehealth. Link
2020: ASTRO Webcast. Covid-19 Telehealth, Supervision, and HIPPA Compliance. Link
2020: Patient Educational Video. Radiation Therapy for Lower Gastrointestinal Cancers. Link
2020: Patient Educational Video. Radiation Therapy for Upper Gastrointestinal Cancers. Link
2020: ASTRO Webinar. E&M Coding for Radiation Oncology. Link
2023: Social Media. Accuray — ASTRO Corporate Sponsor Appreciation Video @ 2023 ASTRO Annual Meeting. Link
2023: ARRO Webinar. Radiation Oncology Case Rate Model. Link
2024: ASTRO Early Career Webinar. Radiation Oncology Case Rate Model. Link
2025: Podcast Guest. Backtable Vascular and Interventional Podcast. Inside the RVS Update Committee Process. Link
2025: Podcast Guest. Progress, Potential, and Possibilities Podcast. Cancer Care, Policy Realities, and Lessons From Abroad. Link
2026: Podcast Guest. ASTRO Rad Onc Report Podcast. ASTRO Q1 2026 Coding Challenges. Link
2026: Podcast Guest. OncoDaily TV Into the Body Podcast. Challenges in Modern Cancer Care and How to Address Them. Link
2026: Podcast Guest. Everybody Talks Podcast. Cancer Screening, Prevention, and the Everyday Exposures That Add Up. Link
Organizational Activities
Institutional Administrative Appointments
2012 – 2020: Representative, Breast Leadership Program, Shady Grove Adventist Medical Center
2012 – 2020: Representative, Commission on Cancer Committee, Shady Grove Adventist Medical Center
2018 – 2020: Representative, Governance Council, Shady Grove Adventist Medical Center
2021 – 2022: Chair, Commission on Cancer Committee, Luminis Health
2022 – 2023: Clinical Liaison Physician, Commission on Cancer Committee, Luminis Health
2021 – Present: Representative, Physician Operations Committee, Luminis Health
2021 – Present: Representative, Breast Steering Committee, Luminis Health
2021 – Present: Representative, Breast Executive Committee, Luminis Health
2022 – Present: Representative, Thoracic Steering Committee, Luminis Health
2023 – Present: Chair, Radiation Oncology Physician Leadership Council, Luminis Health
2023 – Present: Representative, Capital Committee, Luminis Health
2023 – Present: Representative, Medical Advisory Council, Luminis Health
2023 – Present: Chair, Commission on Cancer Committee, Luminis Health
Professional Societies
American Society for Radiation Oncology (ASTRO) — 2009–Present
Board of Directors (2024–2027)
Health Policy and Government Relations Councils:
Chair, Health Policy Council (2026–Present)
Vice-Chair, Health Policy Council (2024–2026)
RUC Advisor (2023–Present), RUC Alternate Advisor (2019–2022)
Chair, Health Policy Committee (2023–2024)
Chair, Code Development and Valuation Subcommittee (2019–2026)
Faculty Presenter and Organizer, Annual Coding and Coverage Seminar (2017–Present)
ASTRO Liaison, ASCO Clinical Care Delivery Council (2017–Present)
Representative, Code Utilization and Application Subcommittee (2017–Present)
Representative, Code Development and Valuation Subcommittee (2017–Present)
HP Fellow (2016–2017)
State Captain Initiative (2011–Present)
Representative, Congressional Relations Subcommittee (2009–Present)
Representative, Payors Relations Subcommittee (2009–2013)
Member, ASTRO (2009–Present)
Corporate Relations:
Chair, Corporate Relations Committee (2025–Present)
Chair, Corporate Advisory Council (2025–Present)
Vice-Chair, Corporate Relations Committee (2023–2025)
Vice-Chair, Corporate Advisory Council (2023–2025)
Member, Corporate Relations Committee (2009–Present)
American College of Radiology (ACR) — 2009–Present
Member, Maryland Chapter Radiological Society, ACR
Alternate Councilor, Maryland Chapter Radiological Society
Representative, Economic Commission (2023–Present)
Chair, Radiation Oncology Economics Committee on Economics (2023–2025)
American Society of Clinical Oncology (ASCO) — 2017–Present
ASTRO Liaison, Clinical Care Delivery Council
Representative, Coding, Billing and Reimbursement Workgroup
Representative, Clinical Practice Council
American Board of Radiology (ABR) — 2009–Present
Member, ABR
American Medical Association (AMA)
Relative Value Update Committee (RUC) ASTRO Alternate Advisor (2019–2022)
Relative Value Update Committee (RUC) ASTRO Advisor (2023–Present)
Representative, Administrative Subcommittee, AMA Relative Value Update Committee (RUC) (2023–Present)
American Radium Society (ARS) — 2009–Present
Member, ARS
Breast Cancer Appropriateness Usage Criteria, Expert Panel (2014–2023)
Representative, Education and Website Development Committee (2020–Present)
Conference Organizer
2017: Organizer and Lecturer — Overview of Radiation Oncology and SRS/SBRT Case Studies. ASTRO Winter Coding and Coverage Seminar, Arlington, Virginia.
2018: Organizer and Lecturer — SRS/SBRT Teaching Session and Case Studies. ASTRO Spring Coding and Coverage Seminar, Arlington, Virginia.
2019: Organizer and Lecturer — SRS/SBRT Teaching Session and Case Studies. ASTRO Coding and Coverage Seminar, Arlington, Virginia.
2020: Organizer and Lecturer — SRS/SBRT Teaching Session and Case Studies. ASTRO Coding and Coverage Seminar, Arlington, Virginia.
2021: Organizer and Lecturer — SRS/SBRT Teaching Session and IMRT Case Studies. ASTRO Coding and Coverage Seminar, Arlington, Virginia.
2022: Organizer and Lecturer — SRS/SBRT Teaching Session and Brachytherapy and IMRT Case Studies. ASTRO Coding and Coverage Seminar, Arlington, Virginia.
2023: Organizer and Lecturer — Introduction, E&M coding, SRS/SBRT, and IMRT Case Studies. ASTRO Coding and Coverage Seminar, Arlington, Virginia.
2025: Organizer and Lecturer — Radiation Oncology Coding and Billing Changes, Non-neoplastic RT coding. ASTRO Coding and Coverage Seminar, Arlington, Virginia.
Scientific Session Moderator/Discussant
2019: Faculty Mentor Discussant — Radiation Oncology Practice Assessment and Contract Negotiations. ARS Annual Meeting, Dana Point, CA.
2019: Scientific Session Moderator — Scientific Breast Session. ARS Annual Meeting, Dana Point, CA.
Journal Peer Review Activities
2016 – Present: Advances in Radiation Oncology Journal, Reviewer
Advisory Committees, Review Groups/Study Sections
2014 – 2023: ARS Breast Cancer Appropriateness Usage Criteria, Expert Panel
2018 – Present: ACR Breast Imaging Appropriateness Criteria, Radiation Oncology Expert
Development of Nationally/Internationally Recognized Clinical Standard of Care
2024: Development of "Quality and Safety Considerations for Adaptive Radiation Therapy: An ASTRO Safety White Paper."
2024: Development of ASTRO Taskforce on Radiopharmaceuticals for Safety and Quality
Research Activities
2009: Designed an IRB approved, phase I, prospective trial on neoadjuvant SBRT for prostate cancer for Robert Wood Johnson Medical School, Rutgers University.
2021–2022: Chair, Protocol Review and Monitoring Committee for Luminis Health Oncology Service Line.
2021–2023: Principal Investigator, SWOG S1827: MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small Cell Lung Cancer (MAVERICK).
2022–Present: Radiation Oncology Voting Representative, Protocol Review and Monitoring Committee for Luminis Health Oncology Service Line.
2024–Present: Principal Investigator, NRG LU008: Phase III Prospective Randomized Trial of Primary Lung Tumor SBRT Followed by Concurrent Mediastinal Chemoradiation for Locally Advanced NSCLC.
2024–Present: Principal Investigator, EF-44 / LUNAR 2: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant with Pembrolizumab and Platinum Based Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer.
Philanthropy
Fund for Education Abroad, Washington, D.C. — 2009–2025 Chairman of the Board (2023–2025) | Vice-Chairman of the Board (2021–2023) | Chair, Nominating and Governance Committee (2021–2023) | Chair, Finance Committee (2019–2023)
Led governance of the nation's largest independent nonprofit study abroad scholarship provider, overseeing the award of more than $3.5 million in scholarships to over 1,000 students.
Organized and led board strategic planning retreats; oversaw the executive director search and succession; developed access-partner revenue agreements returning 30% to operating support.
Denmark International Study Abroad (DIS) Alumni Community Foundation — 2019–Present Vice-Chair, Board of Directors